意大利重症患者呼吸机相关性肺炎的发病率、病原学与死亡率:PROSAFE项目
该研究基于意大利PROSAFE前瞻性多中心观察项目(2014—2023年,192个ICU),分析有创机械通气≥48小时患者的呼吸机相关性肺炎(VAP)特征与结局。主要病原体为假单胞菌属、金黄色葡萄球菌和克雷伯菌属,多药耐药菌及不动杆菌属病原与更高死亡率相关。
要点
- VAP患者ICU住院时间中位数23天,死亡率为30.0%。
- 多药耐药菌和不动杆菌属病原与VAP患者更高死亡率相关。
核心结论
- 在意大利ICU有创机械通气≥48小时的患者中,VAP死亡率为30.0%,且多药耐药菌影响VAP相关死亡率。
研究设计与样本
- PROSAFE为前瞻性多中心观察项目,覆盖192个意大利ICU(2014—2023年),按ECDC的VAP定义记录临床数据。
- 纳入ICU收治患者402 085例,其中有创机械通气≥48小时、被判定为VAP风险者122 430例,共识别VAP病例11 978例。
主要发现
- VAP患者ICU住院时间中位数为23天(Q1—Q3:15—36),死亡率为30.0%。
- VAP主要病原体为假单胞菌属(21.0%)、金黄色葡萄球菌(20.2%)和克雷伯菌属(20.1%)。
- 逻辑回归显示,年龄较大、慢性肝病和肾病、多药耐药菌、不动杆菌属病原及VAP前ICU住院时间与更高死亡率显著相关。
临床怎么用
- 研究强调需要有效且及时的预防策略,以及早期识别VAP病原学。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite preventive measures, ventilator-associated pneumonia (VAP) remains the most common healthcare-associated infection in the intensive care unit (ICU). VAP's striking incidence and impact are a leading cause of morbidity and prolonged ICU stay. This study focused on the characteristics and outcomes of patients diagnosed with ICU-acquired VAPs in Italian ICUs. METHODS: Data were drawn from the PROSAFE network, a prospective multicentric observational project conducted across 192 Italian ICUs (2014-2023). Clinical data were recorded following the European Centre for Disease Prevention and Control VAP definitions. The incidence rate was estimated, and multivariable logistic regression identified ICU mortality risk factors. RESULTS: The patients admitted to the included ICUs were 402 085. Among 122 430 classified at risk for VAP because of invasive mechanical ventilation (IMV) ≥48 hours, a total of 11 978 VAP cases were identified, corresponding to a prevalence of 9.8%. The incidence rate of VAP was 10.47 cases per 1 000 ventilator days (95% CI: 10.28-10.66). Patients with VAP exhibited prolonged ICU stays (median: 23 days, Q1-Q3: 15-36) and high mortality (30.0%). Microbiological profiling of VAP identified Pseudomonas spp. (21.0%), Staphylococcus aureus (20.2%), and Klebsiella spp. (20.1%) as the predominant pathogens. The logistic regression showed that older age, chronic liver and kidney diseases, multidrug-resistant organisms, and Acinetobacter spp. aetiology and duration of ICU stay before VAP were significantly associated with higher mortality. DISCUSSION: While confirming the overall high mortality of patients undergoing IMV, our findings highlight the significantly prolonged ICU stay in VAP patients, and the influence of multidrug-resistant organisms on VAP-related mortality. These insights emphasize the necessity for effective and timely preventive strategies, as well as the early identification of VAP aetiology.
引用
- Colaneri M, Montrucchio G, Scaglione G, et al. Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project. Clin Microbiol Infect. 2025. PMID: 40441355. doi:10.1016/j.cmi.2025.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。